[go: up one dir, main page]

HK1063017A1 - Microgranules based on active principle and method for making same - Google Patents

Microgranules based on active principle and method for making same Download PDF

Info

Publication number
HK1063017A1
HK1063017A1 HK04105869D HK04105869D HK1063017A1 HK 1063017 A1 HK1063017 A1 HK 1063017A1 HK 04105869 D HK04105869 D HK 04105869D HK 04105869 D HK04105869 D HK 04105869D HK 1063017 A1 HK1063017 A1 HK 1063017A1
Authority
HK
Hong Kong
Prior art keywords
active ingredient
core
microparticles
binder
particle size
Prior art date
Application number
HK04105869D
Other languages
English (en)
Chinese (zh)
Inventor
Bruna Etienne
Gendrot Edouard
Cousin Gerard
Original Assignee
Ethypharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm filed Critical Ethypharm
Publication of HK1063017A1 publication Critical patent/HK1063017A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micromachines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK04105869D 2000-11-16 2001-11-15 Microgranules based on active principle and method for making same HK1063017A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR00/14803 2000-11-16
FR0014803A FR2816507B1 (fr) 2000-11-16 2000-11-16 Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules
PCT/FR2001/003584 WO2002039981A1 (fr) 2000-11-16 2001-11-15 Microgranules a base de principe actif et leur procede de fabrication

Publications (1)

Publication Number Publication Date
HK1063017A1 true HK1063017A1 (en) 2004-12-10

Family

ID=8856551

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04105869D HK1063017A1 (en) 2000-11-16 2001-11-15 Microgranules based on active principle and method for making same

Country Status (15)

Country Link
US (1) US7829122B2 (xx)
EP (1) EP1333812B1 (xx)
JP (1) JP4234427B2 (xx)
CN (1) CN1222277C (xx)
AT (1) ATE387187T1 (xx)
AU (2) AU2307402A (xx)
CA (1) CA2427899C (xx)
DE (1) DE60133028T2 (xx)
DK (1) DK1333812T3 (xx)
ES (1) ES2300384T3 (xx)
FR (1) FR2816507B1 (xx)
HK (1) HK1063017A1 (xx)
MX (1) MXPA03004300A (xx)
PT (1) PT1333812E (xx)
WO (1) WO2002039981A1 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796840B1 (fr) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
DE60124895D1 (de) * 2001-07-26 2007-01-11 Ethypharm Sa Umgehüllte Allylamine oder Benzylamine enthaltende Granulate, Verfahren zur Herstellung und in der Mundhöhle dispergierbare Tabletten enthaltend die umgehüllten Granulate
FR2831820B1 (fr) * 2001-11-05 2004-08-20 Ethypharm Sa Comprime orodispersible presentant une grande homogeneite et son procede de preparation
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
FR2850576B1 (fr) * 2003-02-05 2007-03-23 Ethypharm Sa Composition comprenant un melange de principes actifs, et procede de preparation
CN1893956A (zh) * 2003-07-25 2007-01-10 沃纳奇尔科特公司 多西环素金属络合物固体剂型
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
PT2486942T (pt) 2004-11-24 2019-01-18 Meda Pharmaceuticals Inc Composições que compreendem azelastina e seus métodos de utilização
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
AU2006206359B2 (en) * 2005-01-21 2011-03-31 Allergan Pharmaceuticals International Limited A tetracycline metal complex in a solid dosage form
CN101912360A (zh) * 2010-07-13 2010-12-15 山东达因海洋生物制药股份有限公司 布洛芬混悬液及其制备方法
PL2672981T3 (pl) 2011-02-11 2018-09-28 Zx Pharma, Llc Wielocząstkowe preparaty l-mentolu i powiązane sposoby
US8808736B2 (en) 2011-02-11 2014-08-19 Zx Pharma, Llc Enteric coated multiparticulate controlled release peppermint oil composition and related methods
US8911780B2 (en) 2011-02-11 2014-12-16 Zx Pharma, Llc Multiparticulate L-menthol formulations and related methods
DE102012007671A1 (de) 2012-04-16 2013-10-17 Acino Pharma Ag Pellets mit hohem Wirkstoffgehalt
FR2999432B1 (fr) 2012-12-17 2014-12-12 Ethypharm Sa Comprimes orodispersibles obtenus par compression moulage
KR101787225B1 (ko) 2013-04-23 2017-10-18 제트엑스 파마 엘엘씨 단백질성 서브코트를 갖는 장용 코팅된 다중 미립자 조성물
KR102019645B1 (ko) * 2019-02-21 2019-09-09 한국화학연구원 염기성오염물질 제거용 비드 및 이의 제조방법
CN111184694A (zh) * 2020-01-19 2020-05-22 广东青云山药业有限公司 一种口腔速溶颗粒的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions
IT1115596B (it) 1978-03-13 1986-02-03 Bayer Italia Spa Metodo per la preparazione di microgranuli gastoresistenti ed enterosolubili di sostanze farmaceutiche,in particolare di sostanze proteiche e microgranuli preparati con detto metodo
US4248858A (en) * 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
IT1180507B (it) * 1984-06-29 1987-09-23 Roberto Valducci Procedimento per la preparazione di etofibrato o sostanze di pari o simili caratteristiche, in microgunuli-ritardo e prodotto ottenuto con tale procedimento
JPS63188621A (ja) * 1987-01-30 1988-08-04 Taisho Pharmaceut Co Ltd 矯味経口製剤
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
US5344657A (en) * 1988-04-27 1994-09-06 Elf Sanofi Microbeads of diltiazem, a process for their manufacture and a substained-release pharmaceutical composition containing them
JP3078859B2 (ja) 1990-02-23 2000-08-21 武田薬品工業株式会社 安定な放出制御性製剤用コーティング剤
SE9003296L (sv) * 1990-10-16 1992-04-17 Kabi Pharmacia Ab Foerfarande foer att formulera laekemedel
ATE241962T1 (de) 1994-02-16 2003-06-15 Abbott Lab Verfahren zur herstellung feinteiliger pharmazeutischer formulierungen
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug

Also Published As

Publication number Publication date
EP1333812A1 (fr) 2003-08-13
ES2300384T3 (es) 2008-06-16
CA2427899A1 (fr) 2002-05-23
ATE387187T1 (de) 2008-03-15
JP2004517064A (ja) 2004-06-10
PT1333812E (pt) 2008-03-17
WO2002039981A1 (fr) 2002-05-23
CN1222277C (zh) 2005-10-12
US7829122B2 (en) 2010-11-09
US20040101568A1 (en) 2004-05-27
DK1333812T3 (da) 2008-03-31
JP4234427B2 (ja) 2009-03-04
AU2002223074B2 (en) 2005-03-10
EP1333812B1 (fr) 2008-02-27
CA2427899C (fr) 2011-05-10
DE60133028T2 (de) 2009-03-12
DE60133028D1 (de) 2008-04-10
FR2816507B1 (fr) 2003-02-28
FR2816507A1 (fr) 2002-05-17
AU2307402A (en) 2002-05-27
CN1481235A (zh) 2004-03-10
MXPA03004300A (es) 2004-09-10

Similar Documents

Publication Publication Date Title
HK1063017A1 (en) Microgranules based on active principle and method for making same
CN1040061C (zh) 控释药物制剂的制备方法
CN1104891C (zh) 缓释制剂
KR950003609B1 (ko) 지속적 방출성의 제약학적 제제의 제조방법
CN1384739A (zh) 缓释的口服药物形式
CN1178650C (zh) 搅动非依赖性多元缓释药物制剂及其制备方法
JP2000109426A (ja) 薬剤的に活性な粒子の調製方法
CN1419444A (zh) 托吡酯药物组合物
CN1069408A (zh) 球状药用制剂
CN1052788A (zh) 控制释放药物的制剂及其生产方法
CN1236761C (zh) 含有美托洛尔的微粒的制备方法
CN1270025A (zh) 含有含量高达90(重量)%的药物活性成分的小丸的制备方法
CN1328450A (zh) 粒状结晶布洛芬的包衣颗粒
CN1430521A (zh) 具有改善溶出性能的普仑司特的固体分散体系及其制备方法
CN1917860A (zh) 多颗粒o－去甲基文拉法辛盐及其用途
CN1882321A (zh) 包含盐酸文拉法辛的小丸
HK1043945B (zh) 含氯雷他定和伪麻黄碱的药物胶囊组合物
CN1390121A (zh) 硫酸吗啡微粒,其制备方法及含有该物质的组合物
HK1063017B (en) Microgranules based on active principle and method for making same
CN1529587A (zh) 含有粪便软化剂泊洛沙姆和包有肠溶衣的比沙可定颗粒的药物组合物
CN101076318A (zh) 造粒方法
WO2007143959A2 (en) Tablet containing metformin
RU2203042C2 (ru) Фармацевтическая композиция и способ ее получения
CN1256082C (zh) 一种缓释制剂
WO2004089344A1 (ja) 錠剤の製造方法

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20211114